Jeffrey Wiezorek, SVP Clinical Development at Kite Pharma, Inc. (KITE), sold 1,500 shares at $58.17 ($87K) on 2016-09-01, disclosed to the SEC on 2016-09-02.
Open-market sale of $87k KITE by SVP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.17 | 1,238 | $72K | 82.4% |
| 2 | $58.58 | 262 | $15K | 17.6% |
| Total | $58.24 avg | 1,500 | $87K | 100% |
| Filing → |
| KITE | SELL | 2017-03-02 | $1.4M | — | Filing → |
| KITE | SELL | 2017-02-06 | $77K | — | Filing → |
| KITE | SELL | 2017-01-10 | $75K | — | Filing → |